GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives $87.09 Consensus Price Target from Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been assigned a consensus rating of “Moderate Buy” from the twelve ratings firms that are covering the company, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $87.0909.

Several equities analysts have commented on the stock. Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Wells Fargo & Company lowered their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Citigroup boosted their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 15th.

GE HealthCare Technologies Stock Up 0.4%

Shares of GE HealthCare Technologies stock opened at $82.89 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. GE HealthCare Technologies has a 1-year low of $57.65 and a 1-year high of $94.80. The business’s fifty day moving average price is $77.69 and its two-hundred day moving average price is $75.45. The company has a market capitalization of $37.76 billion, a P/E ratio of 17.13, a PEG ratio of 3.46 and a beta of 1.10.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several large investors have recently made changes to their positions in GEHC. Godsey & Gibb Inc. purchased a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. E Fund Management Hong Kong Co. Ltd. grew its holdings in shares of GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares in the last quarter. Allianz SE raised its position in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares during the period. Oakworth Capital Inc. lifted its stake in GE HealthCare Technologies by 1,876.2% in the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after acquiring an additional 394 shares in the last quarter. Finally, Gladwyn Financial Advisors Inc. purchased a new stake in GE HealthCare Technologies in the 2nd quarter worth about $34,000. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.